Randi Hagerman
Medical Director
MIND Institute
From this contributor
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Drug trials for fragile X syndrome lead the way for autism
Several targeted trials on drugs that treat fragile X syndrome are under way. But accurate endpoints to measure the drugs’ effectiveness are crucial, argues developmental and behavioral pediatrician Randi Hagerman.
Drug trials for fragile X syndrome lead the way for autism
Explore more from The Transmitter
‘How to Change a Memory: One Neuroscientist’s Quest to Alter the Past,’ an excerpt
Part scientific exploration, part memoir, Steve Ramirez’s new book delves into the study of memory manipulation and his personal journey of discovery, friendship and grief.
‘How to Change a Memory: One Neuroscientist’s Quest to Alter the Past,’ an excerpt
Part scientific exploration, part memoir, Steve Ramirez’s new book delves into the study of memory manipulation and his personal journey of discovery, friendship and grief.
Journal retracts two papers evaluating ADHD interventions
Frontiers in Public Health retracted one paper for its “unacceptable level of similarity” to another paper, and the other over concerns about its “scientific validity.”
Journal retracts two papers evaluating ADHD interventions
Frontiers in Public Health retracted one paper for its “unacceptable level of similarity” to another paper, and the other over concerns about its “scientific validity.”
Constellation of studies charts brain development, offers ‘dramatic revision’
The atlases could pinpoint pathways that determine the fate of cells linked to neurodevelopmental conditions.
Constellation of studies charts brain development, offers ‘dramatic revision’
The atlases could pinpoint pathways that determine the fate of cells linked to neurodevelopmental conditions.